Back

Impaired systemic microvascular function in patients with resistant arterial hypertension and microalbuminuria: an observational study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Secondary and resistant hypertension Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Eduardo Tibirica

National Institute of Cardiology, Rio de Janeiro (Brazil)

8 More presentations in this session

Presentation thumbnail
Prediction of outcome in malignant hypertension patients using machine learning: a report from the West Birmingham malignant hypertension registry
Doctor A. Argyris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Ten-year outcomes in patients with hypertension and primary hyperaldosteronism undergoing surgical adrenalectomy versus medical therapy: data from the multinational collaborative network TriNetX
Doctor R. Belo Nunes (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
The effect of spironolactone versus eplerenone on blood pressure targets in resistant hypertension patients.
Mrs L. Mishchenko (Kyiv, UA)
Abstract Slides Video
Presentation thumbnail
Cerebral damage after malignant hypertensive crisis: cerebral MRI follow-up data
Doctor J. Liegey (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Semaglutide for the treatment of resistant hypertension
Doctor C. Kennedy (Dublin, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary and resistant hypertension

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention
thumbnail
Congress Presentation
Microvascular function vs. blood pressure in different clinical and non-clinical settings
thumbnail
Congress Presentation
Functinal assessment in Angina and Non-Obstructive Coronary Arteries (ANOCA) patients: from Microvascular Resistance Reserve (MRR) to different subtypes of Coronary Microvascular Dysfunction (CMD)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources